Arkin Bio-Ventures
Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United States, United Kingdom, Canada, Germany, Japan, Australia, China, India, France, Italy, Denmark, Switzerland, Spain, South Korea, Netherlands, Sweden, Belgium, Israel, Norway, Finland
Industries Focus
- Healthcare
- Life Sciences
- Digital Health
- Pharmaceuticals
- Medical Devices
- Diagnostics
- Biotechnology
- Oncology
- Neurology
- Cardiology
- Endocrinology
- Therapeutics
- Immunology
- Genomics
- Biopharmaceuticals
Investment Size:
5,000,000 to 50,000,000 USD
Investor Details Founded: 2010
Arkin Bio-Ventures is a prominent global life sciences venture capital firm specializing in early-stage biotechnology investments. With a strong scientific foundation and extensive industry insights, the firm focuses on identifying and nurturing promising biotech companies across various therapeutic areas. Their portfolio includes investments in innovative sectors such as gene therapy, RNA/DNA-based therapies, and targeted treatments for conditions with high unmet medical needs.
The firm's investment strategy encompasses a broad spectrum of stages, from pre-clinical to clinical development, and spans multiple geographical regions, including Israel, the United States, and Europe. Arkin Bio-Ventures collaborates with top global partners to drive robust growth and impactful advancements in the biotech sector. Their team comprises experts with backgrounds in biopharmaceuticals, drug development, business development, and management, ensuring a comprehensive approach to supporting portfolio companies.
Arkin Bio-Ventures has a proven track record of successful investments, including notable exits such as the acquisition of cCAM Biotherapeutics by Merck in 2015. The firm's commitment to nurturing innovation is evident in its diverse portfolio, which features companies like Keros Therapeutics, HI-Bio, and Eleos Health. By leveraging its vast network and expertise, Arkin Bio-Ventures continues to play a pivotal role in advancing the global biotechnology landscape.
Requirements
- Companies developing innovative therapies in areas of high unmet medical need
- Early-stage biotech companies with strong scientific foundations
- Biotech companies across various therapeutic areas including gene therapy, RNA/DNA-based therapies, and targeted treatments
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Keros Therapeutics
- HI-Bio
- Eleos Health
- Laguna
- Cellebrite
- LendBuzz
- DigitalOcean
- Argo Properties NV
- The Legacy at Baton Rouge
Mentioned In
-
$19.95
-
$19.95
-
$24.95
-
$24.95
-
$24.95
-
$24.95
-
$24.95
-
$24.95
-
$19.95
-
$19.95
-
$99.00
-
$24.95
-
$24.95
-
$19.95
-
$49.95
-
$9.95
-
$19.95
Claim this Investor
Are you an official representative of Arkin Bio-Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim